Literature DB >> 4682585

Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis.

D A Duncan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4682585

Source DB:  PubMed          Journal:  Minn Med        ISSN： 0026-556X


× No keyword cloud information.
  8 in total

1.  Use of intravenous polymyxin B during continuous venovenous hemodialysis.

Authors:  J C Sarria; F Angulo-Pernett; R C Kimbrough; C S McVay; A M Vidal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-06       Impact factor: 3.267

Review 2.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

3.  Colistin neurotoxicity: revisited.

Authors:  Aruna Nigam; Archana Kumari; Reena Jain; Swaraj Batra
Journal:  BMJ Case Rep       Date:  2015-07-23

Review 4.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 5.  Causes of polymyxin treatment failure and new derivatives to fill the gap.

Authors:  Selena Chiu; Anna M Hancock; Bob W Schofner; Katherine J Sniezek; Nashaly Soto-Echevarria; Gabrielle Leon; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2022-09-20       Impact factor: 3.424

6.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.

Authors:  Kade D Roberts; Mohammad A K Azad; Jiping Wang; Andrew S Horne; Philip E Thompson; Roger L Nation; Tony Velkov; Jian Li
Journal:  ACS Infect Dis       Date:  2015-09-04       Impact factor: 5.084

Review 7.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

8.  Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms.

Authors:  Qiong Lu; Guo-Hua Li; Qiang Qu; Hai-Hong Zhu; Yue Luo; Han Yan; Hai-Yan Yuan; Jian Qu
Journal:  Infect Drug Resist       Date:  2021-05-28       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.